4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-23-000245
Director sold 2,000 shares at $122.77 ($245,548)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ALTMAN STEVEN R Director | 2023-12-15 | Sale 10b5-1 | −2,000 | $122.77 | $245,548 | 54,700 | I: show line 1 in the form |
| Open-market sales · 2,000 sh · avg $122.77 · $245,548 | |||||||
Loading xslF345X05/edgardoc.xml…